Effect of smoking on urinary NOx and cGMP excretion in IgA nephropathy and in health

Contributions to Nephrology

Volumn 130, Issue , 2000, Pages 124-129

  Kovács, Tibor ^a   Vas, Tibor ^a   Wagner, László ^a   Schmelczer, Matild ^a   Kocsis, Béla ^b   Nagy, Judit ^a,c  

^a 2nd Department of Medicine   (Hungary)

^b School of Debrecen   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CYCLIC GMP; NITRITE;

ADULT; AGE; ARTICLE; FEMALE; HEALTH; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; METABOLISM; PATHOPHYSIOLOGY; SMOKING; URINE;

ADULT; AGE FACTORS; CREATINE; CYCLIC GMP; FEMALE; GLOMERULONEPHRITIS, IGA; HEALTH; HUMANS; MALE; NITRITES; SMOKING;

EID: 0033642234     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (22)

1. Moncada S, Palmer RMJ, Higgs EA: NO: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-141.
2. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the kidney (editorial review). Am J Physiol 1997;272:F561-F578.
3. Kovács T, Barta J, Kocsis B, Nagy J: Nitric oxide in IgA nephropathy patients with or without hypertension. Exp Nephrol 1995;3:369-372.
4. Tolins JP, Shultz P: Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994;46:230-236.
5. Shultz P, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992;90:1718-1725.
6. Bank N, Aynedijan HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993;43:1306-1312.
7. SeverR, Cook T, Catell V: Urinary excretion of nitrite and nitrate in experimental glomerulonephritis reflects systemicimmune activationandnot glomerular synthesis. Clin Exp Immunol 1992;90:326-329.
8. x) levels in plasma and urine; What does this measure tell us about the activity of the endogenous nitric oxide (NO) system. Curr Opin Nephrol Hypert 1998;7:59-62.
9. Nagy J, Demaster EG,Wittmann I, Shultz P, Raij L: Induction of endothelial cell injury by cigarette smoke. Endothelium 1997;5:251-263.
10. Rocatello D, Mengozzi G, Ferro M, Cesano G, Polloni R, Mosso R, Bonetti G, Inconis T, Paradisi L, Sena LM, Piccoli G: Isosorbid 5 mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelin/cyclic GMP ratio. Clin Nephrol 1995;44:163-169.
11. x/olefin relations: A mechanism for the production of the apparently long-lived radicals in gase-phase cigarette smoke. J Am Chem Soc 1984;106:5073-5079.
12. Church DF, Pryor WA: Free radical chemistry of cigarette smoke and its toxicological implications. Envir Health Persp 1985;64:111-126.
13. Orth SR, Ritz E, Schrier RW: The renal risk of smoking. Kidney Int 1997;51:1669-1677.
14. Guerin MR: Chemical composition of cigarette smoke; in Gori GB, Block FG (eds): Banbury Report: A Safe Cigarette? New York, Cold Spring Harbor Laboratory, 1980, pp 191-204.
15. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskopf I, Kaplan E, Silvberg D, Cabili S, Iaina A: Low nitric oxide production in patients with chronic renal failure. Nephron 1998; 79:265-268.
16. Wong KR, Xie MH, Shi LB, Liu FY, Huang CL, Gardner DG, Cogan MG: Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor. Am J Physiol 1988;255:F1220-F1224.
17. Sagnella GA, Singer DR, MarkanduND, BuckleyMG, MacGregor GA: Is atrial natriuretic peptideguanosine 3'5'-cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension? J Hypertens 1992;10:349-354.
18. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F: L-Arginine infusion induced hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic CMO in humans. Clin Exp Pharmacol Physiol 1992;19:619-625.
19. Grandes S, Gallego MJ, Riesco A, Lopez Farré A, Millas I, Casado S, Hernando L, Caramelo C: Mechanism of renal effects of different agents stimulating production of cGMP. Am J Physiol 1991; 261:H1109-H1114.
20. Boger RH, Bode-Boger SM, Gerecke U, Frolich JC: Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovasc Res 1994;28:494-497.
21. Broadus AE, Kaminsky NI, Hardman JG, Sutherland EW, Liddle GW: Kinetic parameters and renal clearances of plasma adenosine 3'5'-monophosphate and guanosine 3'5'-monophosphate in man. J Clin Invest 1970;49:2222-2236.
22. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Millerr OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.